Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation
Steven Tau(Dartmouth College), Todd W. Miller(Dartmouth College)
Cited by 3
Related Papers
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
|Breast Cancer Research|2011|463
TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha
|Cancers|2024|4
Endocrine therapy induces oxidative stress in ER+ breast cancer that sensitizes persister cells to ferroptosis
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0